Vitreous Hemorrhage

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2007-04-30
EMA Application withdrawn: Vitragan (hyaluronidase) — ISTA Pharma Limited
The EMA withdrew the application for Vitragan (hyaluronidase) by ISTA Pharma Limited for vitreous hemorrhage.